| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|----------------------------------------------------------------------------------------------|

|  ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|-----------------------------------------------------------------------------------------------|

| Nevada                                                        |   | 27- 4677038                         |
|---------------------------------------------------------------|--------|-------------------------------------|
| (State or Other Jurisdiction ofIncorporation or Organization) |   | (I.R.S. EmployerIdentification No.) |
|                                                          |   |                                |
|  1235 Bay St, Suite 400, Toronto, Ontario                |   | M5R 3K4                             |
| (Address of Principal Executive Offices)                      |   | (Zip Code)                          |

| Large accelerated filer  ̈ |   | Accelerated filer  ̈    |
|--------------------------------|--------|-----------------------------|
| Non-accelerated filer  ̈   |   | Smaller reporting company x |

|  Class                    |   | Outstanding as of November 17, 2011 |
|--------------------------------|--------|---------------------------------------------------------|
| Common Stock, $0.001 par value |   | 195,480,000                                             |

----

|                                                                                                     |   | Page   |
|----------------------------------------------------------------------------------------------------------|--------|--------|
| PART I - FINANCIAL INFORMATION                                                                      |   |   |
|                                                                                                     |   |   |
| Item 1. Financial Statements                                                                             |   | 3      |
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |   | 14     |
| Item 3. Quantitative and Qualitative Disclosures About Market Risk                                       |   | 17     |
| Item 4. Controls and Procedures                                                                          |   | 17     |
|                                                                                                     |   |   |
| PART II - OTHER INFORMATION                                                                         |   |   |
|                                                                                                     |   |   |
| Item 1. Legal Proceedings                                                                                |   | 17     |
| Item 1A. Risk Factors                                                                                    |   | 17     |
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds                                      |   | 17     |
| Item 3. Defaults Upon Senior Securities                                                                  |   | 17     |
| Item 4. [Removed and Reserved]                                                                           |   | 18     |
| Item 5. Other Information                                                                                |   | 18     |
| Item 6. Exhibits                                                                                         |   | 18     |
| SIGNATURES                                                                                               |   | 19     |

----

| Consolidated Financial Statements-                                                    |   |   |
|---------------------------------------------------------------------------------------|--------|--------|
|                                                                                  |   |   |
| Consolidated Balance Sheets as of September 30, 2011, and June 30, 2011               |   | 4      |
|                                                                                  |   |   |
| Consolidated Statements of Operations for the Years Ended                             |   |   |
| September 30, 2011, and 2010, and Cumulative from Inception                           |   | 5      |
|                                                                                  |   |   |
| Consolidated Statement of Stockholders’ (Deficit) for the period from Inception |   |   |
| through September 30, 2011                                                            |   | 6      |
|                                                                                  |   |   |
| Consolidated Statements of Cash Flows for the Years Ended                             |   |   |
| September 30, 2011, and 2010, and Cumulative from Inception                           |   |   |
|                                                                                  |   |   |
| Notes to Consolidated Financial Statements September 30, 2011                         |   | 8      |

----

|                                                                                                                                                        |   | September 30, |     |   | June 30, |   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------|----------|--------|---------------|--------|
|                                                                                                                                                        |   | 2011               |     |   | 2011          |   |
| ASSETS                                                                                                                                                      |   |
| Current Assets:                                                                                                                                             |   |               |     |   |          |   |
| Cash                                                                                                                                                        |   | $                  | 1,321    |   |          | $      | 182 |   |
| Prepaid expenses                                                                                                                                            |   |               | 35,833   |   |          |   | 35,833 |   |
| Total current assets                                                                                                                                        |   |               | 37,154   |   |          |   | 36,015 |   |
|                                                                                                                                                        |   |               |     |   |          |   |   |   |
| Total Assets                                                                                                                                                |   | $                  | 37,154   |   |          | $      | 36,015 |   |
|                                                                                                                                                        |   |               |     |   |          |   |   |   |
| LIABILITIES AND STOCKHOLDER'S ( DEFICIT)                                                                                                                    |   |
| Current Liabilities:                                                                                                                                        |   |               |     |   |          |   |   |   |
| Accounts payable and accrued liabilities                                                                                                                    |   | $                  | 146,136  |   |          | $      | 55,639 |   |
| Due to related parties                                                                                                                                      |   |               | 3,403    |   |          |   | 3,403 |   |
| Loan from shareholders                                                                                                                                      |   |               | 99,533   |   |          |   | 60,525 |   |
|                                                                                                                                                        |   |               |     |   |          |   |   |   |
| Total current liabilities                                                                                                                                   |   |               | 249,072  |   |          |   | 119,567 |   |
|                                                                                                                                                        |   |               |     |   |          |   |   |   |
| Total liabilities                                                                                                                                           |   |               | 249,072  |   |          |   | 119,567 |   |
|                                                                                                                                                        |   |               |     |   |          |   |   |   |
| Commitments and Contingencies                                                                                                                               |   |               |     |   |          |   |   |   |
|                                                                                                                                                        |   |               |     |   |          |   |   |   |
| Stockholders' (Deficit):                                                                                                                                    |   |               |     |   |          |   |   |   |
| Common stock, par value $0.001 per share, 200,000,000 shares authorized; 195,480,000 shares issued and outstanding in 2011, (2010: 130,000,000 shares) |   |               | 9,774    |   |          |   | 9,774 |   |
| Preferred stock, par value $0.001 per share, 1,000,000 shares authorized 0 issued and outstanding                                                           |   |               | -        |   |          |   | - |   |
| Additional paid in capital                                                                                                                                  |   |               | 55,493   |   |          |   | 55,493 |   |
| (Deficit) accumulated during the development stage                                                                                                          |   |               | (277,185 | )      |          |   | (148,819 | ) |
|                                                                                                                                                        |   |               |     |   |          |   |   |   |
| Total stockholders' (deficit)                                                                                                                               |   |               | (211,918 | )      |          |   | (83,552 | ) |
|                                                                                                                                                        |   |               |     |   |          |   |   |   |
| Total Liabilities and Stockholder's (Deficit)                                                                                                               |   | $                  | 37,154   |   |          | $      | 36,015 |   |

----

|                                        |   |               |        |   |                  |   |        | Cumulative     |   |
|---------------------------------------------|--------|--------------------|-------------|--------|-----------------------|--------|-------------|----------------|--------|
|                                        |   |               |        |   |                  |   |        | From Inception |   |
|                                        |   | Three Months Ended |        |   | (December 19, 2007)   |   |
|                                        |   | September 30,      |        |   | Through September 30, |   |
|                                        |   | 2011               |        |   | 2010                  |   |        | 2011           |   |
|                                        |   |               |        |   |                  |   |        |           |   |
| Revenues, net                               |   | $                  | -           |   |                  | $      | 1,656       |           |   | $ | 9,506 |   |
|                                        |   |               |        |   |                  |   |        |           |   |   |   |   |
| Cost of Revenues                            |   |               | -           |   |                  |   | 938         |           |   |   | 6,096 |   |
|                                        |   |               |        |   |                  |   |        |           |   |   |   |   |
| Gross Profit                                |   |               | -           |   |                  |   | 718         |           |   |   | 3,410 |   |
|                                        |   |               |        |   |                  |   |        |           |   |   |   |   |
| Expenses:                                   |   |               |        |   |                  |   |        |           |   |   |   |   |
| General and administrative-                 |   |               |        |   |                  |   |        |           |   |   |   |   |
|                                        |   |               |        |   |                  |   |        |           |   |   |   |   |
| Accounting and audit fees                   |   |               | 8,600       |   |                  |   | 1,500       |           |   |   | 27,850 |   |
| Bank charges                                |   |               | 263         |   |                  |   | 263         |           |   |   |   |   |
| Officer compensation                        |   |               | -           |   |                  |   | -           |           |   |   | 6,920 |   |
| Other                                       |   |               | 29,888      |   |                  |   | 1,927       |           |   |   | 56,316 |   |
| Consulting                                  |   |               | 43,877      |   |                  |   | 1,500       |           |   |   | 73,817 |   |
| Legal                                       |   |               | 40,128      |   |                  |   | -           |           |   |   | 88,652 |   |
| Legal - Organization costs                  |   |               | -           |   |                  |   | -           |           |   |   | 775 |   |
| Transfer agent                              |   |               | 5,610       |   |                  |   | -           |           |   |   | 26,002 |   |
|                                        |   |               |        |   |                  |   |        |           |   |   |   |   |
| Total operating expenses                    |   |               | 128,366     |   |                  |   | 4,927       |           |   |   | 280,595 |   |
|                                        |   |               |        |   |                  |   |        |           |   |   |   |   |
| (Loss) from Operations                      |   |               | (128,366    | )      |                  |   | (4,209      | )              |   |   | (277,185 | ) |
|                                        |   |               |        |   |                  |   |        |           |   |   |   |   |
| Other Income (Expense)                      |   |               | -           |   |                  |   | -           |           |   |   | - |   |
|                                        |   |               |        |   |                  |   |        |           |   |   |   |   |
| Provision for Income Taxes                  |   |               | -           |   |                  |   | -           |           |   |   | - |   |
|                                        |   |               |        |   |                  |   |        |           |   |   |   |   |
| Net (Loss)                                  |   | $                  | (128,366    | )      |                  | $      | (4,209      | )              |   | $ | (277,185 | ) |
|                                        |   |               |        |   |                  |   |        |           |   |   |   |   |
| (Loss) Per Common Share:                    |   |               |        |   |                  |   |        |           |   |   |   |   |
| (Loss) per common share - Basic and Diluted |   | $                  | (0.00       | )      |                  | $      | (0.00       | )              |   |   |   |   |
|                                        |   |               |        |   |                  |   |        |           |   |   |   |   |
| Weighted Average Number of Common Shares    |   |               |        |   |                  |   |        |           |   |   |   |   |
| Outstanding - Basic and Diluted             |   |               | 195,480,000 |   |                  |   | 130,000,000 |           |   |   |   |   |

----

|                                              |   |         |        |   |    |   |   |        |   |   | (Deficit)   |   |   |   |     |
|---------------------------------------------------|--------|--------------|-------------|--------|---------|--------|--------|-------------|--------|--------|-------------|--------|--------|--------|----------|
|                                              |   |         |        |   |    |   |   |        |   |   | Accumulated |   |   |   |     |
|                                              |   |         |        |   |    |   |   | Additional  |   |   | During the  |   |   |   |     |
|                                              |   | Common stock |        |   | Paid-in |   |   | Development |   |   |        |   |
| Description                                       |   | Shares       |        |   | Amount  |   |   | Capital     |   |   | Stage       |   |   | Total  |     |
|                                              |   |         |        |   |    |   |   |        |   |   |        |   |   |   |     |
| Balance - December 19, 2007                       |   |         | -           |   |    | $      | -      |        |   | $      | -           |   |   | $      | -        |   |   | $ | - |   |
|                                              |   |         |        |   |    |   |   |        |   |   |        |   |   |   |     |   |   |   |   |   |
| Net (loss) for the period                         |   |         | -           |   |    |   | -      |        |   |   | -           |   |   |   | (1,106   | ) |   |   | (1,106 | ) |
|                                              |   |         |        |   |    |   |   |        |   |   |        |   |   |   |     |   |   |   |   |   |
| Balance - June 30, 2008                           |   |         | -           |   |    |   | -      |        |   |   | -           |   |   |   | (1,106   | ) |   |   | (1,106 | ) |
|                                              |   |         |        |   |    |   |   |        |   |   |        |   |   |   |     |   |   |   |   |   |
| Net (loss) for the year                           |   |         | -           |   |    |   | -      |        |   |   | -           |   |   |   | (661     | ) |   |   | (661 | ) |
|                                              |   |         |        |   |    |   |   |        |   |   |        |   |   |   |     |   |   |   |   |   |
| Balance - June 30, 2009                           |   |         | -           |   |    |   | -      |        |   |   | -           |   |   |   | (1,767   | ) |   |   | (1,767 | ) |
|                                              |   |         |        |   |    |   |   |        |   |   |        |   |   |   |     |   |   |   |   |   |
| Common stock issued for cash at $0.001 per share  |   |         | 130,000,000 |   |    |   | 6,500  |        |   |   | -           |   |   |   | -        |   |   |   | 6,500 |   |
|                                              |   |         |        |   |    |   |   |        |   |   |        |   |   |   |     |   |   |   |   |   |
| Net (loss) for the year                           |   |         | -           |   |    |   | -      |        |   |   | -           |   |   |   | (8,777   | ) |   |   | (8,777 | ) |
|                                              |   |         |        |   |    |   |   |        |   |   |        |   |   |   |     |   |   |   |   |   |
| Balance - June 30, 2010                           |   |         | 130,000,000 |   |    |   | 6,500  |        |   |   | -           |   |   |   | (10,544  | ) |   |   | (4,044 | ) |
|                                              |   |         |        |   |    |   |   |        |   |   |        |   |   |   |     |   |   |   |   |   |
| Common stock issued for cash at $0.0125 per share |   |         | 65,480,000  |   |    |   | 3,274  |        |   |   | 55,493      |   |   |   | -        |   |   |   | 58,767 |   |
|                                              |   |         |        |   |    |   |   |        |   |   |        |   |   |   |     |   |   |   |   |   |
| Net (loss) for the year                           |   |         | -           |   |    |   | -      |        |   |   | -           |   |   |   | (138,275 | ) |   |   | (138,275 | ) |
|                                              |   |         |        |   |    |   |   |        |   |   |        |   |   |   |     |   |   |   |   |   |
| Balance - June 30, 2011 (Forward split 20 for 1)  |   |         | 195,480,000 |   |    |   | 9,774  |        |   |   | 55,493      |   |   |   | (148,819 | ) |   |   | (83,552 | ) |
| Net (loss) for the period                         |   |         | -           |   |    |   | -      |        |   |   | -           |   |   |   | (128,366 | ) |   |   | (128,366 | ) |
|                                              |   |         |        |   |    |   |   |        |   |   |        |   |   |   |     |   |   |   |   |   |
| Balance - September 30, 2011                      |   |         | 195,480,000 |   |    | $      | 9,774  |        |   | $      | 55,493      |   |   | $      | (277,185 | ) |   | $ | (211,918 | ) |

----

|                                                                            |   |                            |     |   | Cumulative           |   |
|---------------------------------------------------------------------------------|--------|---------------------------------|----------|--------|----------------------|--------|
|                                                                            |   |                            |     |   | From Inception       |   |
|                                                                            |   |                            |     |   | (December 19, 2007)  |   |
|                                                                            |   | Three Months EndedSeptember 30, |     |   | ThroughSeptember 30, |   |
|                                                                            |   | 2011                            |     |   | 2010                 |   |   | 2011 |   |
|                                                                            |   |                            |     |   |                 |   |   |   |   |
| Operating Activities:                                                           |   |                            |     |   |                 |   |   |   |   |
| Net (loss)                                                                      |   | $                               | (128,366 | )      |                 | $      | (4,209 | ) |   | $ | (300,266 | ) |
| Adjustments to reconcile net (loss) to net cash (used in) operating activities: |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Changes in Current Assets and Liabilities-                                      |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Prepaid expenses                                                                |   |                            | -        |   |                 |   | - |   |   |   | (35,833 | ) |
| Accounts payable and accrued liabilities                                        |   |                            | 90,497   |   |                 |   | 13,423 |   |   |   | 169,680 |   |
|                                                                            |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Net Cash Provided by (Used in) Operating Activities                             |   |                            | (37,869  | )      |                 |   | 9,214 |   |   |   | (166,419 | ) |
|                                                                            |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Investing Activities:                                                           |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Purchases of property and equipment                                             |   |                            | -        |   |                 |   | - |   |   |   | - |   |
|                                                                            |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Net Cash Provided by (Used in) Investing Activities                             |   |                            | -        |   |                 |   | - |   |   |   | - |   |
|                                                                            |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Financing Activities:                                                           |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Contributions from related party                                                |   |                            | -        |   |                 |   | - |   |   |   | 17,842 |   |
| Proceeds from issuance of common stock                                          |   |                            | -        |   |                 |   | - |   |   |   | 47,425 |   |
| Loan from shareholders                                                          |   |                            | 39,008   |   |                 |   | - |   |   |   | 97,931 |   |
| Deferred offering costs                                                         |   |                            | -        |   |                 |   | (11,880 | ) |   |   | - |   |
| Due to related parties                                                          |   |                            | -        |   |                 |   | 1,500 |   |   |   | 3,403 |   |
|                                                                            |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Net Cash Provided by (Used in) Financing Activities                             |   |                            | 39,008   |   |                 |   | (10,380 | ) |   |   | 166,601 |   |
|                                                                            |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Net Increase in Cash                                                            |   |                            | 1,139    |   |                 |   | (1,166 | ) |   |   | 182 |   |
|                                                                            |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Cash - Beginning of Period                                                      |   |                            | 182      |   |                 |   | 2,902 |   |   |   | - |   |
|                                                                            |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Cash - End of Period                                                            |   | $                               | 1,321    |   |                 | $      | 1,736 |   |   | $ | 182 |   |
|                                                                            |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Supplemental Disclosure of Cash Flow Information:                               |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Cash paid during the period for:                                                |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Interest                                                                        |   | $                               | -        |   |                 | $      | - |   |   | $ | - |   |
|                                                                            |   |                            |     |   |                 |   |   |   |   |   |   |   |
| Income taxes                                                                    |   | $                               | -        |   |                 | $      | - |   |   | $ | - |   |

----

|   | 1. | CRAM – Contract Research and Manufacturing for Life Sciences Companies |
|--------|----|------------------------------------------------------------------------------|

|   | 2. | HEALTHCARE INNOVATION – Novel Drug and Device Delivery Format Packaging |
|--------|----|-------------------------------------------------------------------------------|

|   | 3. | BIOPHARMA PARTNERSHIPS – Strategic Development and Production Alliances |
|--------|----|-------------------------------------------------------------------------------|

----

----

----

----

|                          |   | Three Months Ended |    |
|-------------------------------|--------|------------------------------|---------|
|                          |   | September 30,           |    |
|                          |   | 2011                         |    |   | 2010 |   |
|                          |   |                         |    |   |   |   |
| Current Tax Provision:        |   |                         |    |   |   |   |
| Federal                       |   |                         |    |   |   |   |
| Taxable income                |   | $                            | -       |   |   | $ | - |   |
|                          |   |                         |    |   |   |   |   |   |
| Total current tax provision   |   | $                            | -       |   |   | $ | - |   |
|                          |   |                         |    |   |   |   |   |   |
| Deferred Tax Provision:       |   |                         |    |   |   |   |   |   |
| Federal                       |   |                         |    |   |   |   |   |   |
| Loss carryforwards            |   | $                            | 41,578  |   |   | $ | 2,213 |   |
| Change in valuation allowance |   |                         | (41,578 | ) |   |   | (2,213 | ) |
|                          |   |                         |    |   |   |   |   |   |
| Total deferred tax provision  |   | $                            | -       |   |   | $ | - |   |

|                          |   | September 30, |     |   | June 30, |   |
|-------------------------------|--------|--------------------|----------|--------|---------------|--------|
|                          |   | 2011               |     |   | 2011          |   |
|                          |   |               |     |   |          |   |
| Loss carryforwards            |   | $                  | 277,185  |   |          | $      | 148,819 |   |
| Less - Valuation allowance    |   |               | (277,185 | )      |          |   | (148,819 | ) |
|                          |   |               |     |   |          |   |   |   |
| Total net deferred tax assets |   | $                  | -        |   |          | $      | - |   |

----

|   | · | An entity that holds a group of financial assets and financial liabilities whose market risk (that is, interest rate risk, currency risk, or other price risk) and credit risk are managed on the basis of the entity’s net risk exposure may apply an exception to the fair value requirements in ASC 820 if certain criteria are met. The exception allows such financial instruments to be measured on the basis of the reporting entity’s net, rather than gross, exposure to those risks. |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | · | In the absence of a Level 1 input, a reporting entity should apply premiums or discounts when market participants would do so when pricing the asset or liability consistent with the unit of account. |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | · | Additional disclosures about fair value measurements. |
|--------|--------|-------------------------------------------------------|

----

|   | 1. | On August 12, 2011, the Company filed an amendment to its Certificate of Incorporation to increase the number of shares that the Company is authorized to issue from 75,000,000 shares of common stock to 200,000,000 shares of common stock, $0.001 par value per share, and to authorize the issuance of 1,000,000 shares of preferred stock, $0.001 par value per share. |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | On August 18, 2011, the Company implemented a 20 for 1 forward split of its shares of common stock outstanding.  All owners of record at the close of business on August 23, 2011 (record date) received 19 additional shares for every one share they owned as of the record date of August 23, 2011.  |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3. | On August 4, 2011, through MDRM Group (Canada) Ltd. the Company entered into a share exchange agreement to acquire all of the outstanding common stock of Lumigene Technologies, Inc. Lumigene is, a corporation organized in Ontario, Canada, in the business of developing point of source infectious disease diagnostic machines which will enable health professionals to quickly and effectively diagnose and treat infectious diseases.  Its products are the subject of ongoing research and development efforts.  |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Balance Sheet Data: |   | 09/30/11 |     |   | 06/30/11 |   |
|-------------------------------|--------|----------|----------|--------|----------|--------|
|                          |   |     |     |   |     |   |
| Cash                          |   | $        | 1,321    |   |     | $      | 182 |   |
| Total assets                  |   | $        | 37,154   |   |     | $      | 36,015 |   |
| Total liabilities             |   | $        | 249,072  |   |     | $      | 119,567 |   |
| Shareholders' equity          |   | $        | (211,918 | )      |     | $      | (83,552 | ) |

----

----

----

| Exhibit No. |         | Description                                                                                                                                                                                                                                                                                                                                                      |
|------------------|--------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|             |         |                                                                                                                                                                                                                                                                                                                                                             |
|   3.1  |         | Articles of Incorporation (i)**                                                                                                                                                                                                                                                                                                                                  |
|   3.2  |         | Bylaws (i)**                                                                                                                                                                                                                                                                                                                                                     |
|   3.3  |         | Certificate of Amendment to Articles of Incorporation***                                                                                                                                                                                                                                                                                                         |
| 10.2             |         | Share Purchase Agreement dated August 4, 2011 between MDRM Group (Canada) Ltd. (of the first part), Michalkoff Family Trust, Hrycyshyn Family Trust and Stolarchuk Family Trust (of the second part), Lumigene Technologies Inc. (of the third part) and Mark Michalkoff, Roman Hrycyshyn and Danylo Stolarchuk (of the fourth part). ****                       |
| 10.3             |         | Amendment to Share Purchase Agreement dated as of November 4, 2011 between MDRM Group (Canada) Ltd. (of the first part), Michalkoff Family Trust, Hrycyshyn Family Trust and Stolarchuk Family Trust (of the second part), Lumigene Technologies Inc. (of the third part) and Mark Michalkoff, Roman Hrycyshyn and Danylo Stolarchuk (of the fourth part). ***** |
| 31.1             |         |  Section 302 Certification of Chief Executive Officer*                                                                                                                                                                                                                                                                                                      |
| 31.2             |         | Section 302 Certification of Chief Financial Officer *                                                                                                                                                                                                                                                                                                           |
| 32.1             |         | Section 906 Certification of Chief Executive Officer *                                                                                                                                                                                                                                                                                                           |
| 32.2             |    | Section 906 Certification of Chief Financial Officer *                                                                                                                                                                                                                                                                                                           |

| *     |   | filed herewith                                                                                                     |
|-------|--------|--------------------------------------------------------------------------------------------------------------------|
| **    |   | Included in our S-1 filing on August 23, 2010.                                                                     |
| ***   |   | Included in our current report on Form 8-K filed with the Securities and Exchange Commission on August 18, 2011.   |
| ****  |   | Included in our current report on Form 8-K filed with the Securities and Exchange Commission on August 10, 2011.   |
| ***** |   | Included in our current report on Form 8-K filed with the Securities and Exchange Commission on November 10, 2011. |

----

|   | MODERN MOBILITY AIDS INC. |
|--------|---------------------------|
|   |                      |
|   | By:                       | /s/  Mohamed K. Karatella |
|   |                      | Mohamed K. Karatella |
|   |                      | President, (Principal Executive Officer) Acting ChiefFinancial Officer, Treasurer, (Acting PrincipalAccounting Officer) and Director |

----